Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: Appropriate programming

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 5, 2011, Pages 778-790

  Koneru, Jayanthi N ^a   Swerdlow, Charles D ^b   Wood, Mark A ^a   Ellenbogen, Kenneth A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Death sudden cardiac; Implantable cardioverter defibrillators; Tachycardia ventricular

Indexed keywords

ALGORITHM; CARDIOVERSION; COMPUTER PROGRAM; DEFIBRILLATOR; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; TIME;

DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; SOFTWARE; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 84555205699     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.961243     Document Type: Review

References (73)

1. Pedersen SS, Van Den Berg M, Erdman RA, Van Son J, Jordaens L, Theuns DA. Increased anxiety in partners of patients with a cardioverterdefibrillator: the role of indication for ICD therapy, shocks, and personality. Pacing Clin Electrophysiol. 2009;32:184-192.
2. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics. 2005;46:451-457. (Pubitemid 46173204)
3. Vollmann D, Luthje L, Vonhof S, Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter defibrillator. Heart Rhythm. 2005;2:307-309. (Pubitemid 40309831)
4. Healy E, Ngarmukos T, Rosenthal L. A case of bad timing: inappropriate implantable cardioverter defibrillator therapy due to a critically placed premature ventricular contraction. Pacing Clin Electrophysiol. 2002;25: 1403-1405.
5. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365. (Pubitemid 351443082)
6. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7:353-360.
7. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120:835-842.
8. Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S, Ip JH, Peress DF, Ramadas S, Massumi A. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: Results from the PROVE trial. J Cardiovasc Electrophysiol. 2010;21:1349-1354.
9. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48: 330-339.
10. Swerdlow CD. Sensing and detection. In Ellenbogen KA, Kay GN, Lau CP, and Wilkoff BL. Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. Edinburgh, UK: Elsevier Saunders; 2007:75-162.
11. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011; 57:556-562.
12. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
13. Kuhlkamp V, Wilkoff BL, Brown AB, Volosin KJ, Hugl BJ, Stafford W, Cameron DA. Experience with a dual chamber implantable defibrillator. Pacing Clin Electrophysiol. 2002;25:1041-1048. (Pubitemid 34828057)
14. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 2001;104:796-801. (Pubitemid 32762678)
15. Gunderson BD, Abeyratne AI, Olson WH, Swerdlow CD. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks. Pacing Clin Electrophysiol. 2007;30:157-165. (Pubitemid 46333670)
16. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J. 2009;30:2758-2767.
17. Wilkoff B, Williamson B, Stern R, Moore S, Lu F, Lee S, Birgersdotter-Green U, Wathen M, Van Gelder I, Heubner B, Brown M, Holloman K. Strategic programming of detection and therapy parameters in implantable defibrillators reduces shocks in primary prevention patients: results from the PREPARE study. J Am Coll Cardiol. 2008;52: 541-550.
18. Wilkoff BL. Late breaking clinical trials: programming strategies associated with shock reduction in 88804 implantable defibrillator patients. Paper presented at: Heart Rhythm Society 31st Annual Scientific Sessions; May 2010; Denver, CO.
19. Swerdlow CD, Shehata M. Antitachycardia pacing in primary-prevention ICDs. J Cardiovasc Electrophysiol. 2010;21:1355-1357.
20. Swerdlow CD, Chen PS, Kass RM, Allard JR, Peter CT. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol. 1994;23: 1342-1355. (Pubitemid 24158002)
21. Russo AM, Nayak H, Verdino R, Springman J, Gerstenfeld E, Hsia H, Marchlinski FE. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified? Pacing Clin Electrophysiol. 2003;26:2289-2295. (Pubitemid 38037542)
22. Dorian P, Philippon F, Newman D, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A. A randomized controlled study of detection enhancements versus rate only detection to prevent inappropriate therapy in a dual chamber implantable cardioverter defibrillator. Heart Rhythm. 2004;1:540-547. (Pubitemid 39462711)
23. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol. 1998;9:261-268. (Pubitemid 28180463)
24. Kettering K, Dornberger V, Lang R, Vonthein R, Suchalla R, Bosch RF, Mewis C, Eigenberger B, Kuhlkamp V. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol. 2001;24:1325-1333. (Pubitemid 32881958)
25. Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C, Dorian P, Moore H, Duru F, Rooney E, Becker D, Schaaf K, Benditt D. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol. 2006;17:1310-1319. (Pubitemid 44808550)
26. Swerdlow CD, Brown ML, Lurie K, Zhang J, Wood NM, Olson WH, Gillberg JM. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol. 2002;13: 432-441. (Pubitemid 34494261)
27. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002;13:1092-1097. (Pubitemid 35379608)
28. Toquero J, Alzueta J, Mont L, Lozano IF, Barrera A, Berruezo A, Castro V, Pena JL, Fidalgo ML, Brugada J. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish register of morphology discrimination criterion wavelet (REMEDIO). Europace. 2009;11:727-733.
29. Kuhlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol. 1999;10:905-915. (Pubitemid 29297709)
30. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol. 2001;12:134-142. (Pubitemid 32171500)
31. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. 2004;44:2362-2367. (Pubitemid 39647611)
32. Bansch D, Steffgen F, Gronefeld G, Wolpert C, Bocker D, Mletzko RU, Schols W, Seidl K, Piel M, Ouyang F, Hohnloser SH, Kuck KH. The 1-1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation. 2004;110:1022-1029.
33. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia (DETECT SVT) study. Circulation. 2006; 113:2871-2879. (Pubitemid 44297227)
34. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace. 2008;10:528-535. (Pubitemid 351775295)
35. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation. 2001;103:381-386. (Pubitemid 32105977)
36. Weber M, Bocker D, Bansch D, Brunn J, Castrucci M, Gradaus R, Breithardt G, Block M. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 1999;10:145-153. (Pubitemid 29115236)
37. Sadoul N, Jung W, Jordaens L, Leenhardt A, Santini M, Wolpert C, Aliot E. Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol. 2002;13:25-32. (Pubitemid 34113616)
38. Asirvatham SJ, Bruce CJ, Danielsen A, Johnson SB, Okumura Y, Kathmann E, Packer DL, Friedman PA. Intramyocardial pacing and sensing for the enhancement of cardiac stimulation and sensing specificity. Pacing Clin Electrophysiol. 2007;30:748-754. (Pubitemid 46850039)
39. de Voogt W, van Hemel N, Willems A, Visser J, Chitre Y, Bornzin G, Helland J. Far-field R-wave reduction with a novel lead design: experimental and human results. Pacing Clin Electrophysiol. 2005;28:782-788. (Pubitemid 41648219)
40. Sticherling C, Zabel M, Spencker S, Meyerfeldt U, Eckardt L, Behrens S, Niehaus M. Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study. Circ Arrhythm Electrophysiol. 2011;4:56-63.
41. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591-2596. (Pubitemid 39453007)
42. Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004; 27:1292-1305. (Pubitemid 39281927)
43. Grimm W, Plachta E, Maisch B. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverterdefibrillator therapy. Pacing Clin Electrophysiol. 2006;29:759-764. (Pubitemid 44060745)
44. Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiaranda G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Circ Arrhythm Electrophysiol. 2009;2: 146-153.
45. Yee R, Birgersdotter-Green U, Belk P, Jackson T, Christensen J, Wathen MS. The relationship between pacing site and induction or termination of sustained monomorphic ventricular tachycardia by antitachycardia pacing. Pacing Clin Electrophysiol. 2010;33:27-32.
46. Bernier M, Essebag V. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging. Pacing Clin Electrophysiol. 2010;33:e81-e83.
47. Schoels W, Steinhaus D, Johnson WB, O'Hara G, Schwab JO, Jenniskens I, Degroot PJ, Tang F, Helmling E. Optimizing implantable cardioverterdefibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. Heart Rhythm. 2007;4:879-885. (Pubitemid 46959199)
48. Grimm W, Menz V, Hoffmann J, Maisch B. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm. Pacing Clin Electrophysiol. 1998;21:722-727.
49. Raedle-Hurst TM, Wiecha J, Schwab JO, Schmitt H, Hinrichs M, Tillmanns H, Waldecker B. Clinical performance of a specific algorithm to reconfirm self-terminating ventricular arrhythmias in current implantable cardioverter-defibrillators. Am J Cardiol. 2001;88:744-749.
50. Srivathsan K, Scott LR, Altemose GT. T-wave oversensing and inappropriate shocks: a case report. Europace. 2008;10:552-555. (Pubitemid 351775303)
51. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter- defibrillator leads. Circulation. 2008;118:2122-2129.
52. Gunderson BD, Swerdlow CD, Wilcox JM, Hayman JE, Ousdigian KT, Ellenbogen KA. Causes of ventricular oversensing in implantable cardioverter- defibrillators: implications for diagnosis of lead fracture. Heart Rhythm. 2010;7:626-633.
53. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Sachanandani H, Ellenbogen KA. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverterdefibrillator lead fractures: a prospective study. Circulation. 2010;122: 1449-1455.
54. Swerdlow CD, Sachanandani H, Gunderson BD, Ousdigian KT, Hjelle M, Ellenbogen KA. Preventing overdiagnosis of implantable cardioverter- defibrillator lead fractures using device diagnostics. J Am Coll Cardiol. 2011;57:2330-2339.
55. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: part I. Pacing Clin Electrophysiol. 2005;28:1322-1346. (Pubitemid 43951394)
56. Seegers J, Zabel M, Luthje L, Vollmann D. Ventricular oversensing due to manufacturer-related differences in implantable cardioverterdefibrillator signal processing and sensing lead properties. Europace. 2010;12:1460-1466.
57. Sweeney MO, Ruetz LL, Belk P, Mullen TJ, Johnson JW, Sheldon T. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J Am Coll Cardiol. 2007;50:614-622. (Pubitemid 47199010)
58. Martínez-Sánchez J, García-Alberola A, Sánchez-Muñoz JJ, Peñafiel-Verdú P, Giner-Caro JA, Valdés-Chávarri M. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias. Pacing Clin Electrophysiol. 2009;32:1096-1098.
59. Cron TA, Schaer B, Osswald S. Implantable cardioverter defibrillator proarrhythmia due to an interaction with "noncompetitive atrial pacing": an algorithm to prevent atrial arrhythmias. Pacing Clin Electrophysiol. 2002;25:1656-1659. (Pubitemid 35398932)
60. Lee JC, Epstein LM, Huffer LL, Stevenson WG, Koplan BA, Tedrow UB. ICD lead proarrhythmia cured by lead extraction. Heart Rhythm. 2009;6:613-618.
61. Gronefeld GC, Israel CW, Padmanabhan V, Koehler J, Cuijpers A, Hohnloser SH. Ventricular rate stabilization for the prevention of pause dependent ventricular tachyarrhythmias: results from a prospective study in 309 ICD recipients. Pacing Clin Electrophysiol. 2002;25:1708-1714. (Pubitemid 36026881)
62. Friedman PA, Jalal S, Kaufman S, Villareal R, Brown S, Hahn SJ, Lerew DR. Effects of a rate smoothing algorithm for prevention of ventricular arrhythmias: results of the Ventricular Arrhythmia Suppression Trial (VAST). Heart Rhythm. 2006;3:573-580.
63. Wietholt D, Kuehlkamp V, Meisel E, Hoffmann E, Stellbrink C, Neuzner J, Seidl K, Szigat P, Potratz J. Prevention of sustained ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators- the PREVENT study. J Interv Card Electrophysiol. 2003;9: 383-389. (Pubitemid 37521595)
64. Sweeney MO. A novel cause of pacing-facilitated short-long-short onset sequence ventricular tachycardia in the DDD/R mode: what is the mechanism? Heart Rhythm. 2008;5:1760-1762.
65. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverterdefibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998;32:1909-1915. (Pubitemid 29010454)
66. Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol. 2000;11:1208-1214.
67. Gradaus R, Seidl K, Korte T, Himmrich E, Wieneke H, Schuchert A, Bauer W, Gerss J, Wollmann CG, Borggrefe M, Bocker D. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF study. Europace. 2007;9:534-539. (Pubitemid 47249445)
68. Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA, Viswanathan S, Chetaille P, Gordon E, Dore A, Cecchin F. Sudden death and defibrillators in transposition of the great arteries with intraatrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008; 1:250-257.
69. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370.
70. Khairy P, Mansour F. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips. Heart Rhythm. 2011;8: 480-483.
71. Lewandowski M, Sterlinski M, Maciag A, Syska P, Kowalik I, Szwed H, Chojnowska L, Przybylski A. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming. Europace. 2010;12:1245-1250.
72. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C. Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325-332.
73. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181-1189.